Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02774759 · ClinicalTrials.gov registry record · NA
Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers
A NA study of Malignant Neoplasms of Female Genital Organs, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT02774759: Active NA study of Malignant Neoplasms of Female Genital Organs, sponsored by M.D. Anderson Cancer Center.
NCT02774759 is a NA study of Malignant Neoplasms of Female Genital Organs that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 15 participants, below the 41-participant average among 5 other Malignant Neoplasms of Female Genital Organs trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02774759, a NA study of Malignant Neoplasms of Female Genital Organs, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to learn if a home-based physical activity program is feasible and can help endometrial cancer survivors lose weight.
Primary Outcome
Study considered feasible if consent rate is larger than 40%.
Conditions Studied
Interventions
- BEHAVIORAL Resistance Training
- BEHAVIORAL Questionnaires
- DEVICE Accelerometer
- BEHAVIORAL Aerobic Exercise
- BEHAVIORAL Fitness Test
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-10-17 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT02774759 still lists
NCT02774759 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 41-participant average among 5 other Malignant Neoplasms of Female Genital Organs trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Malignant Neoplasms of Female Genital Organs appearing as the primary indexed condition, and to 5 interventions - of which Resistance Training is the first listed.
NCT02774759 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02774759 about?
NCT02774759 is a clinical study titled "Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers". The goal of this research study is to learn if a home-based physical activity program is feasible and can help endometrial cancer survivors lose weight.
What is the current status of trial NCT02774759?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2016-10-17. Estimated completion is 2026-12-31.
What conditions does trial NCT02774759 study?
This clinical trial studies the following conditions: Malignant Neoplasms of Female Genital Organs.
What interventions are being tested in trial NCT02774759?
The interventions under investigation include: Resistance Training (BEHAVIORAL), Questionnaires (BEHAVIORAL), Accelerometer (DEVICE), Aerobic Exercise (BEHAVIORAL), Fitness Test (BEHAVIORAL).
Who is sponsoring clinical trial NCT02774759?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02774759 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasms of Female Genital Organs
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
RECRUITING · Phase 1
-
Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
ACTIVE NOT RECRUITING · Phase 2
-
Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery
ACTIVE NOT RECRUITING · Phase 2
-
Selumetinib and Olaparib in Solid Tumors
ACTIVE NOT RECRUITING · Phase 1
-
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI